TAS-108 also known as SR16234 is a drug discovered by Masato Tanabe and under development by SRI International and Taiho Pharmaceutical. It is a steroid hormone that has showed signs of treating and preventing breast cancer even in patients where tamoxifen has failed.
This page contains content from the copyrighted Wikipedia article "TAS-108"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.